Activity of Imipenem/Relebactam and Comparators Against Gram-Negative Pathogens from Patients with Bloodstream Infections in the United States and Canada – SMART 2018-2019

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

(2019) Daniel J. Diekema et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem Non-susceptible Pseudomonas aeruginosa from Intensive Care Units in the United States: A Potential Role for New β-lactam Combination Agents

(2019) Tomefa E Asempa et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

(2019) Katherine Young et al.   BMC MICROBIOLOGY

In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program

(2018) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OUP accepted manuscript

(2018)   CLINICAL INFECTIOUS DISEASES

Activity of Imipenem-Relebactam against Gram-Negative Bacilli from Global ICU and Non-ICU Wards — SMART 2015-2016

(2018) Sibylle H. Lob et al.   Journal of Global Antimicrobial Resistance

Activity of Imipenem-Relebactam against Pseudomonas aeruginosa with Antimicrobial-Resistant Phenotypes from Seven Global Regions—SMART 2015-2016

(2018) James A. Karlowsky et al.   Journal of Global Antimicrobial Resistance

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014

(2016) Lindsey M. Weiner et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Bloodstream infections in the Intensive Care Unit

(2016) Matteo Bassetti et al.   Virulence

Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City

(2015) Amabel Lapuebla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY